CLINICAL_TRIALS
trial_result
· 2009-11-03
Clinical Trial Update: A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma. [Phase 2]
Summary
A pivotal Phase 2 trial of SU011248 in cytokine-refractory metastatic renal cell carcinoma has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: COMPLETED | Results posted: 2009-11-03